87 related articles for article (PubMed ID: 1526627)
1. Incidence and characteristics of microprolactinomas (3-5 mm) in 4199 women assayed for prolactin.
Batrinos ML; Panitsa-Faflia C; Tsiganou E; Liapi C
Horm Metab Res; 1992 Aug; 24(8):384-91. PubMed ID: 1526627
[TBL] [Abstract][Full Text] [Related]
2. Contribution to the problem of hyperprolactinaemia: experience with 4,199 prolactin assays and 117 prolactinomas.
Batrinos ML; Panitsa-Faflia C; Tsiganou E; Pitoulis G; Liapi C
Int J Fertil Menopausal Stud; 1994; 39(2):120-7. PubMed ID: 8012441
[TBL] [Abstract][Full Text] [Related]
3. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
[TBL] [Abstract][Full Text] [Related]
4. Gender-related differences in prolactin secretion in pituitary prolactinomas.
Nishioka H; Haraoka J; Akada K; Azuma S
Neuroradiology; 2002 May; 44(5):407-10. PubMed ID: 12012125
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effects of melatonin on the development of 17-beta-estradiol induced prolactinoma in relation to plasma prolactin and peroxidative lipid contents].
Gao L; Xu JP; Shan HM; Zhang R; Xu RK
Sheng Li Xue Bao; 2001 Jun; 53(3):165-9. PubMed ID: 12589398
[TBL] [Abstract][Full Text] [Related]
7. [The value of functional tests in diagnosis of prolactinoma].
Klockenbusch W; Distler W; von Ditfurth M; Graf M; Jahn K
Geburtshilfe Frauenheilkd; 1990 May; 50(5):383-7. PubMed ID: 2115483
[TBL] [Abstract][Full Text] [Related]
8. Prolactinomas in children and adolescents--consequences in adult life.
Duntas LH
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1227-32; discussion 1261-2. PubMed ID: 11964017
[TBL] [Abstract][Full Text] [Related]
9. MRI--diagnostic and follow-up tool for microprolactinomas.
Seidl Z; Obenberger J; Marek J; Hána V; Vanĕcková M
Funct Neurol; 2000; 15(1):47-51. PubMed ID: 10842760
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of determining serum levels of prolactin in women with menstruation disorders].
Starzewski J; Niespodziański K; Kowalski D; Kowalska K; Piasek G; Chlewicka B
Przegl Lek; 1989; 46(10):728-31. PubMed ID: 2594991
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hypothalamic dopaminergic function in patients with pituitary prolactinoma.
Xia P; Shi YF
Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(3):121-5. PubMed ID: 2594732
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels.
Smith MV; Laws ER
Neurosurgery; 1994 May; 34(5):834-9; discussion 839. PubMed ID: 8052379
[TBL] [Abstract][Full Text] [Related]
13. Microprolactinomas in males treated by transsphenoidal surgery.
Wolfsberger S; Czech T; Vierhapper H; Benavente R; Knosp E
Acta Neurochir (Wien); 2003 Nov; 145(11):935-40; discussion 940-1. PubMed ID: 14628197
[TBL] [Abstract][Full Text] [Related]
14. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
[TBL] [Abstract][Full Text] [Related]
15. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
16. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
[TBL] [Abstract][Full Text] [Related]
17. The hook effect in prolactin immunoassays.
Al Sifri SN; Raef H
Saudi Med J; 2004 May; 25(5):656-9. PubMed ID: 15138537
[TBL] [Abstract][Full Text] [Related]
18. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
Hildebrandt G; Bauer T; Stracke H; Fassbender WJ; Mueller HW; Agnoli AL; Federlin K; Roosen K
Zentralbl Neurochir; 1992; 53(3):123-34. PubMed ID: 1414079
[TBL] [Abstract][Full Text] [Related]
19. [Prolactinoma].
Krysiak R; Okopień B; Marek B; Szkróbka W
Przegl Lek; 2009; 66(4):198-205. PubMed ID: 19708510
[TBL] [Abstract][Full Text] [Related]
20. Prolactin (PRL) release in normal and growth hormone deficient children after oral metoclopramide.
Preeyasombat C; Mahachoklertwattana P; Sriphrapradang A; Choubtam L
J Med Assoc Thai; 1993 Oct; 76 Suppl 2():34-41. PubMed ID: 7823004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
